A prospective study of cyclosporine monitoring in renal transplantation.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Transplantation Proceedings

• Publication date

  1990-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 2190388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing

  2004cited by this paper
• Cyclosporine monitoring with polyclonal and specific monoclonal antibodies during episodes of renal allograft dysfunction.

  1989cited by this paper
• Monitoring of cyclosporine blood levels with polyclonal and monoclonal assays during episodes of renal graft dysfunction.

  1989cited by this paper
• The continuing need for quality assessment of cyclosporine measurement.

  1989cited by this paper
• Influence of early cyclosporine dosage and plasma and whole blood levels on acute rejections in cadaveric renal allograft recipients.

  1988cited by this paper
• Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood.

  1988cited by this paper
• Minimal low dosage of cyclosporine therapy in renal transplantation by careful monitoring of high-performance liquid chromatography whole blood trough levels.

  1988cited by this paper
• Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring.

  1987cited by this paper
• Monoclonal antibodies to ciclosporin.

  1986cited by this paper
• Blood cyclosporin concentrations and renal allograft dysfunction.

  1986cited by this paper
• Cyclosporine blood concentrations in the management of renal transplant recipients.

  1986cited by this paper
• Clinical Pharmacokinetics of Cyclosporin

  1986cited by this paper
• Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.

  1985cited by this paper
• Cyclosporin blood levels do correlate with clinical complications.

  1984cited by this paper
• The value of serial serum trough cyclosporine levels in human renal transplantation.

  1984cited by this paper
• Immunological and pharmacological monitoring in the clinical use of cyclosporin A.

  1981cited by this paper

• A Logistic-Regression Model Provides Novel Guidelines to Maximize the Anti-Acute Rejection Properties of Cyclosporine with a Minimum of Toxicity1

  2005cites this paper
• THE CLINICAL IMPACT OF NEPHROTOXICITY IN RENAL TRANSPLANTATION

  2000cites this paper
• A logistic-regression model provides novel guidelines to maximize the anti-acute rejection properties of cyclosporine with a minimum of toxicity.

  1996cites this paper
• The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy

  1996cites this paper
• The therapeutic window of cyclosporine in Chinese recipients of renal transplantation.

  1995cites this paper
• Laboratory Analysis of Cyclosporine

  1991cites this paper
• A delay in correlation between cyclosporine dosage and trough level measurements

  1991cites this paper
• Summary on therapeutic drug monitoring for renal transplantation.

  1990cites this paper
• Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.

  1990cites this paper